October 7, 2008
| Bio-IT World > Quantum Dot Thinks Big
Quantum Dot Thinks Big


<% pageTitle = "Quantum Dot Thinks Big" articleid = "4421" localnav = "" section = "Archive" author = "" contributer = "BIO-IT World" publicationDate = "2004-02-18" description = "Its glowing nanocrystals light up cell analysis and diagnostics" idgurl = "http://www.bio-itworld.com/archive/021804/horizons_dot.html" copyright = "2004" keywords = "" adsite = "idg.us.bioitw.archives" ad468x60 = "yes" ad150x800 = "yes" ad336x280 = "no" adSpecial1 = "no" adSpecial2 = "no" adSpecial3 = "no" adSpecial4 = "no" serviceCenterComment = "no" serviceCenterSubscribe = "yes" serviceCenterReprint = "no" serviceCenterPrint = "yes" serviceCenterClickability = "yes" serviceCenterEmailPage = "yes" serviceCenterEmailArticle = "no" %> Horizons

COMPANY TO WATCH | Its glowing nanocrystals light up cell analysis and diagnostics

By Stephen Lawson, IDG News Service

February 18, 2004 | People pay good money for Quantum Dot's products — tiny semiconductors just about 10 nanometers across. To pharmaceutical companies, medical researchers, and diagnostic labs, these "quantum dots" are more valuable than precious metals. They buy small, brightly colored vials, priced from $300 to $600, each containing trillions of the dots in solution — enough for about 100 tests. Then they look at them.

Light Bright: Quantum Dot's Qdot nanocrystals provide five-color multiplexing in a fixed human epithelial cell; nucleus (cyan), Ki-67 (magenta), mitochondria (orange), microtubules (green), and actin filaments (red).

The best thing about Quantum Dot's semiconductor crystals — known as Qdot nanocrystals — is that you can see them: inside cells, under a microscope, or in multiple colors under the same light, depending on their size and composition. They're brighter than fluorescent proteins and dyes, and remain lit much longer, according to Andy Watson, vice president of business development.

Qdots are being used for cell analysis, gene expression, and medical diagnostics. By studying the glowing crystals, which can bond with proteins, researchers can track those proteins to learn about cells in a sample. Other applications include analyzing the genetic makeup of cancer cells and determining how well a cancer drug binds its target.

Quantum Dot was founded in 1998 with licenses to discoveries by Moungi Bawendi at MIT and Paul Alivisatos of University of California at Berkeley. Those researchers discovered biological applications of quantum dots, which had been developed in the 1980s for use in physics research. The company has raised more than $37.5 million in financing so far, and the Forbes/Wolfe Nanotech Report recently named their technology one of the top breakthroughs of 2003.

Quantum Dot Essentials

Focus: Biological detection

Scientific founders: Paul Alivisatos and Moungi Bawendi

Current funding: Over $37.5 million

Investors: Versant Ventures, Abingworth Management, Technogen Associates, Schroder Ventures, Frazier & Co., MPM Asset Management, CMEA Ventures

Current staff: 55

Location: Hayward, Calif.
Quantum Dot manufactures in a lab setting at the company's headquarters. When technicians combine cadmium and selenium in a solution and apply heat, the elements form semiconductor crystals. Modifying the process slightly can change the size and composition of the crystals so that they will glow in different colors. Zinc and sulfur are added to the mix, forming a shell around each crystal. Then the crystals are coated with molecules to create conjugates, which can hook up with proteins.

Companies such as Genentech have used Qdots to determine the concentration of substances in a sample, such as new cancer drugs that are supposed to target certain parts of cells. And researchers are attaching Qdots to single molecules to track their activity. One team used Qdots to study the behavior of glycine receptors in neurons.

Neurotransmitters travel from one neuron to another and then bond with receptors on a synapse. Observing the activity of those receptors in real time, the researchers found that they were very active, moving to different parts of a synapse, to other synapses, and to areas outside the synapses, says research scientist Maxime Dahan.

The miniature size and long-lasting lucidity of the Qdots allowed the scientists to record the activity of receptors in real time in live cultured neurons. Much larger probes would not have worked, as the receptors are only about 5 nanometers wide. "The motion of these receptors with the large probe on its back is going to be modified, and you don't get a real view of the natural motion," Dahan says. "Now we realize that these [receptors] ... are not stable at all — they keep moving all the time." The discovery could lead to better drug design if researchers can determine how to change the number of receptors at a given synapse.

The success of Dahan and colleagues illustrates the potential of Qdots to study single molecules, especially for tracking multiple targets simultaneously, says Adam Douglass, a cell biologist at University of California at San Francisco.


Partner Program
A recent deal with Matsushita Electric Industrial has produced a device for studying samples treated with Qbead microspheres — linked combinations of Qdot nanocrystals. As many as 200 uniquely coded microspheres with attached probes can be made from combinations of nanocrystals, so researchers can detect expression of 200 different genes in a sample. The system lets researchers study hundreds of genes in thousands of samples per day.

The microspheres are sensitive enough to detect as few as 100,000 molecules of RNA — much more sensitive than microarrays — according to Quantum Dot. Matsushita will make the device, called the Quantum Dot Mosaic Q100 Scanner.

The glowing crystals may also find their way into quick "strip" tests, similar to instant pregnancy tests, as a result of a partnership with the Jet Propulsion Laboratory at the California Institute of Technology. This technology could be used to test for substances associated with heart conditions and prostate cancer, Watson says.

Qdots can show not only whether a substance exists in a sample but how much of it is there. Eventually, Qdots could end up in inexpensive, over-the-counter test kits. That would be a big future for a very small product.







Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

sas whitepaper92Managed Innovation, Assured Compliance 
sponsored by SAS
Discovery organizations are identifying a lot of promising compounds, but clinical research processes haven't kept pace with timely testing of all those potential therapies. This white paper describes how SAS® Drug Development supports true innovation across the clinical trial process.

In this white paper you will learn how to:

  • Assemble data to foster better collaboration
  • Get up-to-date information during clinical trials
  • Make informed decisions earlier in the trial process
    Download now 


BlueArc white paper image 1

Addressing Life Sciences Constantly Growing Data Challenges Research Environments
sponsored by BlueArc
The continued explosion of raw experimental data, the increased use of video, the growing adoption of new data retention practices, and the move to high throughput computational workflows are all placing new demands on the way life sciences organizations store and manage their data.

Download this white paper to learn about:

  • Factors driving the data explosion in the life sciences
  • New data management issues that must be addressed
  • HPC trends that are placing new demands on storage
  • Storage solution attributes that address performance, manageability, and energy efficiency. Download now 


isilon white paper

“Storage for Science – Methods for Managing Large and Rapidly Growing Data Stores in Life Science Research Environments” sponsored by Isilon
Large and rapidly growing stores of file-based and other data are a hallmark of life science research and bioinformatics. Determining how best to manage those data stores has become a significant challenge for Researchers and IT Pros alike.

This paper is intended to:

  • Provide guidance on the many storage requirements common to Life Science research;
  • Explain the evolution of modern storage architectures;
  • Summarize the major data storage architectures currently in use.

Additionally, it will present the Isilon IQ clustered storage product as a strong and flexible solution to those needs. Download now



Life Science Webcasts & Podcasts

Adobe

Hospital Paperwork No Longer Has to Be an In-patient Procedure 

Adobe podcast imageHow many times have you filled out that same patient registration form when visiting a doctor or the hospital? If you are a hospital administrator, nurse or registrar, you know that your patients and particularly your staff have managed hundreds of consent forms for medication, procedures, anesthesia, and HIPAA. Paperwork redundancy has become a significant bottleneck in the healthcare system. In this podcast, we’ll learn about how Adobe solutions for healthcare can help you streamline your paperwork and stop making paperwork an in-patient procedure.

Download Now 



More Podcasts

Job Openings

Oxford Nanopore Technologies, Oxford, UK
We seek a highly motivated individual to lead the administration, expansion and maintenance of our IT infrastructure, supporting our business operations and technological development of a DNA third generation sequencing system.  Includes administration and configuration of core corporate servers, high performance scientific computing and disk systems, security systems, network infrastructure and backups, maintenance of service levels, implementation of any IT related legal compliance issues and policies, and disaster recovery. to apply: www.nanoporetech.com/vacancies

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.